Maynard Um
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY)
-
-
-
-
-
-
-
Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $37 at Goldman Sachs
-
-
-
-
-
-
-
Harmony Biosciences reports positive pitolisant bioequivalence study results
-
-
-
-
-
-
-
Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $55 at H.C. Wainwright
-
-
-
-
-
-
-
Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $50 at Mizuho
-
-
-
-
-
-
-
Mizuho Reiterates Outperform Rating on Harmony Biosciences Holdings Inc. (HRMY)
-
-
-
-
-
-
-
Oppenheimer on Harmony Biosciences (HRMY): 'we remain pleased with WAKIX's 4Q24 performance'
-
418,488 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

